Cardiac Sarcoidosis and Consequent Arrhythmias

Cardiac Electrophysiology Clinics

Volumn 7, Issue 2, 2015, Pages 235-249

  Zipse, Matthew M ^a   Sauer, William H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Atrioventricular block; Cardiac sarcoidosis; Sudden cardiac death; Ventricular arrhythmias

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ATRIOVENTRICULAR BLOCK; CATHETER ABLATION; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART BUNDLE BRANCH BLOCK; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CONDUCTION SYSTEM; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; SCREENING; SINUS NODE DISEASE; SUDDEN CARDIAC DEATH; TREATMENT INDICATION; CARDIOMYOPATHY;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; HUMANS; SARCOIDOSIS;

EID: 84930274932     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2015.03.006     Document Type: Review

References (57)

1. Chapelon-Abric C., de Zuttere D., Duhaut P., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine 2004, 83:315-334.
2. Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978, 58:1204-1211.
3. Uusimaa P., Ylitalo K., Anttonen O., et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008, 10:760-766.
4. Birnie D.H., Sauer W., Bogun F., et al. Heart Rhythm Society expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014, 11(7):1-24.
5. Soejima K., Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. JCardiovasc Electrophysiol 2009, 20:578-583.
6. Mehta D., Mori N., Goldbarg S.H., et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2011, 4:43-48.
7. Aizer A., Stern E.H., Gomes J.A., et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005, 96:276-282.
8. Boulos M., Lashevsky I., Reisner S., et al. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. JAC. JAm Coll Cardiol 2001, 38:2020-2027.
9. Nery P.B., Keren A., Healey J., et al. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol 2013, 29:1015.e1-1015.e3.
10. Pieroni M., Russo Dello A., Marzo F., et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy. JAm Coll Cardiol 2009, 53:681-689.
11. Vasaiwala S.C., Finn C., Delpriore J., et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. JCardiovasc Electrophysiol 2009, 20:473-476.
12. Santucci P.A., Morton J.B., Picken M.M., et al. Electroanatomic mapping of the right ventricle in a patient with a giant epsilon wave, ventricular tachycardia, and cardiac sarcoidosis. JCardiovasc Electrophysiol 2004, 15:1091-1094.
13. Vakil K., Minami E., Fishbein D.P. Right ventricular sarcoidosis: is it time for updated diagnostic criteria?. Tex Heart Inst J 2014, 41:203-207.
14. Matsui Y., Iwai K., Tachibana T., et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976, 278:455-469.
15. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977, 63:86-108.
16. Schuller J.L., OLSON M.D., Zipse M.M., et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. JCardiovasc Electrophysiol 2011, 22:1243-1248.
17. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013, 127:e283-e352.
18. Betensky B.P., Tschabrunn C.M., Zado E.S., et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012, 9:884-891.
19. Kato Y., Morimoto S.-I., Uemura A., et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20:133-137.
20. Yodogawa K., Seino Y., Ohara T., et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011, 16:140-147.
21. Yoshida Y., Morimoto S., Hiramitsu S., et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997, 134:382-386.
22. Kandolin R., Lehtonen J., Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011, 4:303-309.
23. Nery P.B., Beanlands R.S., Nair G.M., et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. JCardiovasc Electrophysiol 2014, 25(8):875-881.
24. Gozo E.G., Cosnow I., Cohen H.C., et al. The heart in sarcoidosis. Chest 1971, 60:379-388.
25. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979, 97:701-707.
26. Viles-Gonzalez J.F., Pastori L., Fischer A., et al. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 2013, 143:1085-1090.
27. Cain M.A., Metzl M.D., Patel A.R., et al. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Am J Cardiol 2014, 113:1556-1560.
28. Schuller J.L., Zipse M., Crawford T., et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. JCardiovasc Electrophysiol 2012, 23:925-929.
29. Zipse M.M., Schuller J.L., Katz D.F., et al. Atrial arrhythmias are common and arise from diverse mechanisms in patients with cardiac sarcoidosis. Heart Rhythm 2013, 2013:1-2.
30. Willner J.M., Viles-Gonzalez J.F., Coffey J.O., et al. Catheter ablation of atrial arrhythmias in cardiac sarcoidosis. JCardiovasc Electrophysiol 2014, 25(9):958-963.
31. Winters S.L., Cohen M., Greenberg S., et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. JAm Coll Cardiol 1991, 18:937-943.
32. Koplan B.A., Soejima K., Baughman K., et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006, 3:924-929.
33. Jefic D., Joel B., Good E., et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 2009, 6:189-195.
34. Banba K., Kusano K.F., Nakamura K., et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007, 4:1292-1299.
35. Furushima H., Chinushi M., Sugiura H., et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004, 27:217-222.
36. Fleming H.A., Bailey S.M. Sarcoid heart disease. JR Coll Physicians Lond 1981, 15:245.
37. Nery P.B., Mc Ardle B.A., Redpath C.J., et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2014, 37:364-374.
38. Stees C.S., Khoo M.S., Lowery C.M., et al. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. JCardiovasc Electrophysiol 2011, 22:210-213.
39. Yazaki Y., Isobe M., Hiroe M., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001, 88:1006-1010.
40. Mohsen A., Jimenez A., Hood R.E., et al. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. JCardiovasc Electrophysiol 2013, 25(2):171-176.
41. Naruse Y., Sekiguchi Y., Nogami A., et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol 2014, 7:407-413.
42. Kron J., Sauer W., Schuller J., et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 2013, 15:347-354.
43. Schuller J.L., Lowery C.M., Zipse M., et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011, 16:70-76.
44. Youssef G., Beanlands R.S.B., Birnie D.H., et al. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 2011, 97:2078-2087.
45. Blankstein R., Osborne M., Naya M., et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. JAm Coll Cardiol 2014, 63:329-336.
46. Ohira H., Tsujino I., Ishimaru S., et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008, 35:933-941.
47. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002, 122:1895-1901.
48. Sekiguchi M., Yazaki Y., Isobe M., et al. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996, 10:495-510.
49. Greulich S., Deluigi C.C., Gloekler S., et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013, 6:501-511.
50. Writing Committee Members, Epstein A.E., DiMarco J.P., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for implantation of cardiac pacemakers and Antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:2820-2840.
51. Hamzeh N.Y. Management of cardiac sarcoidosis in the United States. Chest 2012, 141:154.
52. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. NEngl J Med 2005, 352:225-237.
53. Zipse M.M., Varosy P.D., Schuller J.L., et al. Patients with cardiac sarcoidosis and ICDs have a high incidence of late reduction of measured electrograms. Heart Rhythm 2013, 2013:1-2.
54. Curtis A.B., Worley S.J., Adamson P.B., et al. Biventricular pacing for atrioventricular block and systolic dysfunction. NEngl J Med 2013, 368:1585-1593.
55. Okamoto H., Mizuno K., Ohtoshi E. Cutaneous sarcoidosis with cardiac involvement. Eur J Dermatol 1999, 9:466-469.
56. Yodogawa K., Seino Y., Shiomura R., et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. JCardiol 2013, 62:320-325.
57. Dechering D.G., Kochhäuser S., Wasmer K., et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2013, 10:158-164.